CardioSight Inc. develops the CardioSight intracardiac visualization and intervention platform. It provides minimally invasive intracardiac device guidance and delivery under direct, near-field optical visualization.
As the contract developer we design and develop the entire device in close collaboration with our customer. We assembled various iterations of prototypes and completed both in vitro testing at Semmelweis University and in vivo testing with our customer at Boston University.
Our complex and broad support enables CardioSight to stay a small Start-up company focusing on fundamental start-up management activities.